Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma
Abstract Background We previously identified an oncogenic role for the transcription factor HNF1A in pancreatic ductal adenocarcinoma (PDAC). However, the role of HNF1A in the metastatic progression of PDAC remains unknown and targeting modalities for HNF1A-dependent phenotypes have yet to be identi...
Saved in:
| Main Authors: | Katherine J. Crawford, Kennedy S. Humphrey, Eduardo Cortes, Jianxin Wang, Vishnu Kumarasamy, Yin Wan, Mark D. Long, Michael E. Feigin, Agnieszka K. Witkiewicz, Karen M. Mann, Erik S. Knudsen, Ethan V. Abel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02408-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1–4 mutated solid tumors
by: Jiyu Huang, et al.
Published: (2025-08-01) -
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
by: Jinhao Chen, et al.
Published: (2025-03-01) -
FGFR2-Rearrangement in Intrahepatic and Extrahepatic Cholangiocarcinoma and Prognostic Analysis
by: Guo J, et al.
Published: (2025-06-01) -
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
by: Maxim Noeraparast, et al.
Published: (2024-10-01) -
Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4
by: Qing Luo, et al.
Published: (2025-07-01)